The store will not work correctly when cookies are disabled.
3-[(2(S)-Azetidinyl)methoxy]-5-[(1R,2S)-2-(2-methoxyethyl)-cyclopropyl]pyridine
ID: ALA2024095
PubChem CID: 56951497
Max Phase: Preclinical
Molecular Formula: C15H22N2O2
Molecular Weight: 262.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COCC[C@@H]1C[C@H]1c1cncc(OC[C@@H]2CCN2)c1
Standard InChI: InChI=1S/C15H22N2O2/c1-18-5-3-11-7-15(11)12-6-14(9-16-8-12)19-10-13-2-4-17-13/h6,8-9,11,13,15,17H,2-5,7,10H2,1H3/t11-,13+,15-/m1/s1
Standard InChI Key: NMIIKXFGCKOYRV-OSAQELSMSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
8.4411 -5.2631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2063 -5.5713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0912 -4.7528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2985 -5.6833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2974 -6.5107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0122 -6.9235 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7286 -6.5102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7258 -5.6797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0104 -5.2705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5840 -5.2710 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8696 -5.6836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1550 -5.2713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9368 -4.4715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1400 -4.6852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3537 -5.4821 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8676 -5.2591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5836 -5.6689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2966 -5.2537 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.2934 -4.4287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 5 2 0
4 10 1 0
1 2 1 0
10 11 1 0
5 6 1 0
12 11 1 1
12 13 1 0
2 3 1 0
6 7 2 0
1 3 1 0
13 14 1 0
14 15 1 0
15 12 1 0
1 8 1 6
7 8 1 0
2 16 1 1
16 17 1 0
8 9 2 0
17 18 1 0
9 4 1 0
18 19 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 262.35 | Molecular Weight (Monoisotopic): 262.1681 | AlogP: 1.96 | #Rotatable Bonds: 7 |
Polar Surface Area: 43.38 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.79 | CX LogP: 0.90 | CX LogD: -1.43 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.82 | Np Likeness Score: 0.43 |
References
1. Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP.. (2012) Chemistry and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile., 55 (2): [PMID:22171543] [10.1021/jm201157c] |